A COVID-19 vaccine would challenge tech leadership and spark a rotation into value, Goldman Sachs says

· *The successful development of a COVID-19 vaccine would drive the stock market higher, but expect beaten-down value stocks to lead the rally rather than tech stocks, according to Goldman Sachs.*
· *In a note published on Wednesday, Goldman said stocks are "setting up for a shift in leadership across markets," with a vaccine...